News Focus
News Focus
icon url

IB2011

04/13/11 5:47 PM

#118188 RE: jq1234 #118187

Totally overpriced. Compare MNTA to Biogen. Yes, I know, MNTA is much smaller but they have a better business model with less risk.
icon url

DewDiligence

04/13/11 5:56 PM

#118189 RE: jq1234 #118187

Two Icahn engagements in recent years, two different outcomes…

Three if you count ImClone :- )

The strange thing about the Biogen-Idec merger is that Idec was nominally the acquiring company and yet there is no trace of it left other than the Roche JV.